XBIT:US
$2.64
-4.348%
XBiotech Inc.News & Events
Last updated: Jun 14, 2025, 12:57 AM ET
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT
PR Newswire FEB 4, 2025 4:20 PM ESTINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - ...READ ARTICLEXBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm
PR Newswire JAN 17, 2025 5:19 AM ESTXBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Fir...READ ARTICLEWolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating XBiotech for potential violations of securities laws
GlobeNewswire JAN 14, 2025 4:37 PM ESTPLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK, Jan. 14, 2025 (GLOBE NEWS...READ ARTICLEXBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm
Business Wire JAN 13, 2025 7:04 PM ESTThe Schall Law Firm , a national shareholder rights litigation firm, announces that it is inves...READ ARTICLESHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT
PR Newswire JAN 8, 2025 12:00 PM ESTSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc....READ ARTICLESHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT
PR Newswire JAN 2, 2025 10:10 AM ESTSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc....READ ARTICLESHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc. - XBIT
PR Newswire DEC 27, 2024 4:20 PM ESTSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc....READ ARTICLEXBiotech Pauses Rheumatology program
GlobeNewswire DEC 23, 2024 9:00 AM ESTAUSTIN, Texas, Dec. 23, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today dat...READ ARTICLEXBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer
GlobeNewswire JUN 18, 2024 11:35 AM EDTAUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today dat...READ ARTICLEMarket Influences That Drive Equities Forward - New Research on Galena Biopharma, XBiotech, KEMET and Control4
ACCESS Newswire DEC 24, 2015 8:05 AM ESTNEW YORK, NY / ACCESSWIRE / December 24, 2015 / Moments ago, Trader's Choice released new re...READ ARTICLE